Northwestern Mutual Wealth Management Co. reduced its position in shares of Oracle Corporation (NYSE:ORCL – Free Report) by 3.7% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 527,219 shares of the enterprise software provider’s stock after selling 20,432 shares during the period. Northwestern Mutual Wealth Management Co.’s holdings in Oracle were worth $77,264,000 at the end of the most recent reporting period.
Several other institutional investors have also added to or reduced their stakes in ORCL. HFM Investment Advisors LLC lifted its position in shares of Oracle by 290.9% during the 4th quarter. HFM Investment Advisors LLC now owns 129 shares of the enterprise software provider’s stock worth $25,000 after buying an additional 96 shares during the last quarter. Basepoint Wealth LLC bought a new position in Oracle in the fourth quarter valued at about $26,000. FSA Wealth Management LLC acquired a new position in Oracle during the third quarter worth about $28,000. Osbon Capital Management LLC bought a new position in shares of Oracle in the fourth quarter worth about $28,000. Finally, Basso Capital Management L.P. acquired a new stake in shares of Oracle in the 4th quarter valued at approximately $29,000. 42.44% of the stock is currently owned by institutional investors and hedge funds.
Key Oracle News
Here are the key news stories impacting Oracle this week:
- Positive Sentiment: Oracle reported $638 billion in remaining performance obligations at fiscal 2026 year-end, up 363% year over year. The backlog provides significant long-term revenue visibility, although management expects only 12% to convert to revenue within the next 12 months. Oracle Has $638 Billion of Contracted Backlog and a $430 Billion Stock
- Positive Sentiment: Analysts continue to point to Oracle’s cloud and AI growth potential. TD Cowen maintained a Buy rating despite reducing its price target to $240, while other commentary described ORCL as potentially undervalued relative to its cloud and AI opportunity. Oracle Slides as Cowen Cuts Target
- Positive Sentiment: Oracle Health expanded its Clinical AI Agent in the United States, adding automation for documentation, coding and chart-review workflows within electronic health records. The rollout could strengthen Oracle’s position in healthcare technology and support its broader AI strategy. Oracle Health Using Healthcare AI
- Neutral Sentiment: Oracle’s next quarterly report is approaching, and analysts expect another earnings beat based on its historical surprise record. Investors will focus on cloud growth, backlog conversion, capital spending and updated financing plans. Why Oracle Is Poised to Beat Earnings Estimates Again
- Negative Sentiment: Fiscal 2026 free cash flow was negative $23.7 billion as Oracle accelerated data-center investment. The company raised $43 billion in debt and expects to raise roughly $40 billion more in fiscal 2027, increasing sensitivity to higher interest rates and execution risk. Why Is Oracle Stock Down Today
- Negative Sentiment: TD Cowen’s target reduction highlighted concerns that spending is arriving before revenue, while a global bond selloff is pressuring highly leveraged AI infrastructure companies. Rising yields reduce the attractiveness of ORCL’s debt-funded expansion and future cash flows. Oracle Falls as Bond Selloff Tests AI Buildout
- Negative Sentiment: EU antitrust regulators are examining Oracle’s licensing practices, according to a Reuters source. A regulatory case similar to SAP’s could create compliance costs, concessions or restrictions on Oracle’s commercial model. Oracle Licensing Practices on EU Antitrust Radar
- Negative Sentiment: Renewed geopolitical tensions, higher global bond yields and broader technology-sector weakness further reduced investor risk appetite, adding pressure to ORCL alongside company-specific balance-sheet concerns. SoundHound AI, Fastly and Oracle Shares Plummet
Insider Buying and Selling
Oracle Trading Down 5.5%
ORCL opened at $140.99 on Wednesday. Oracle Corporation has a fifty-two week low of $114.50 and a fifty-two week high of $345.72. The company has a debt-to-equity ratio of 3.21, a current ratio of 1.12 and a quick ratio of 1.12. The firm has a market capitalization of $406.12 billion, a price-to-earnings ratio of 24.18, a PEG ratio of 0.93 and a beta of 1.74. The company’s 50 day moving average price is $139.73 and its two-hundred day moving average price is $160.44.
Oracle (NYSE:ORCL – Get Free Report) last released its quarterly earnings results on Wednesday, June 10th. The enterprise software provider reported $2.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.96 by $0.15. Oracle had a net margin of 25.37% and a return on equity of 58.62%. The firm had revenue of $19.18 billion during the quarter, compared to the consensus estimate of $19.10 billion. During the same quarter last year, the firm earned $1.70 earnings per share. The company’s revenue for the quarter was up 20.6% on a year-over-year basis. Oracle has set its Q1 2027 guidance at 1.720-1.760 EPS and its FY 2027 guidance at 8.050-8.050 EPS. As a group, research analysts predict that Oracle Corporation will post 6.49 earnings per share for the current year.
Oracle Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Friday, July 24th. Shareholders of record on Friday, July 10th were issued a dividend of $0.50 per share. The ex-dividend date of this dividend was Friday, July 10th. This represents a $2.00 annualized dividend and a yield of 1.4%. Oracle’s payout ratio is presently 34.31%.
Analysts Set New Price Targets
Several equities research analysts recently issued reports on ORCL shares. Stephens reaffirmed an “equal weight” rating and set a $164.00 price target on shares of Oracle in a report on Thursday, June 11th. Oppenheimer raised their target price on shares of Oracle from $235.00 to $275.00 and gave the company an “outperform” rating in a research report on Monday, June 8th. BTIG Research reaffirmed a “buy” rating and set a $400.00 target price on shares of Oracle in a research note on Friday, June 5th. Arete Research set a $255.00 price target on shares of Oracle and gave the stock a “buy” rating in a report on Thursday, May 7th. Finally, Wolfe Research reiterated an “outperform” rating and issued a $225.00 price target on shares of Oracle in a research note on Thursday, June 11th. Two analysts have rated the stock with a Strong Buy rating, twenty-eight have assigned a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $262.39.
View Our Latest Stock Report on Oracle
About Oracle
Oracle Corporation is a multinational technology company that develops and sells database software, cloud engineered systems, enterprise software applications and related services. The company is widely known for its flagship Oracle Database and a portfolio of enterprise-grade software products that support data management, application development, analytics and middleware. Over recent years Oracle has expanded its focus to include cloud infrastructure and cloud applications, positioning itself as a provider of both platform and software-as-a-service solutions for large organizations.
Oracle’s product and service offerings include Oracle Database and the Autonomous Database, Oracle Cloud Infrastructure (OCI), enterprise resource planning (ERP), human capital management (HCM) and supply chain management (SCM) cloud applications (often grouped under Oracle Fusion Cloud Applications), middleware such as WebLogic, and developer technologies including Java and MySQL.
Featured Stories
- Five stocks we like better than Oracle
- Dutch Bros Sell-Off Creates a Growth Opportunity
- NVIDIA’s MediaTek Bet Shows How It Plans to Defend Its AI Moat
- Is Abercrombie & Fitch’s Hot Streak Just Getting Started?
- Medtronic’s Stars Are Aligning for a Price Recovery
Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.
